117 related articles for article (PubMed ID: 38479704)
1. ALKBH5-mediated upregulation of CPT1A promotes macrophage fatty acid metabolism and M2 macrophage polarization, facilitating malignant progression of colorectal cancer.
Sun M; Yue Y; Wang X; Feng H; Qin Y; Chen M; Wang Y; Yan S
Exp Cell Res; 2024 Apr; 437(1):113994. PubMed ID: 38479704
[TBL] [Abstract][Full Text] [Related]
2. RNA demethylase ALKBH5 promotes ovarian carcinogenesis in a simulated tumour microenvironment through stimulating NF-κB pathway.
Jiang Y; Wan Y; Gong M; Zhou S; Qiu J; Cheng W
J Cell Mol Med; 2020 Jun; 24(11):6137-6148. PubMed ID: 32329191
[TBL] [Abstract][Full Text] [Related]
3. ALKBH5 modulates macrophages polarization in tumor microenvironment of ovarian cancer.
An Y; Duan H
J Ovarian Res; 2024 Apr; 17(1):84. PubMed ID: 38637813
[TBL] [Abstract][Full Text] [Related]
4. RNA demethylase ALKBH5 promotes colorectal cancer progression by posttranscriptional activation of RAB5A in an m6A-YTHDF2-dependent manner.
Shen D; Lin J; Xie Y; Zhuang Z; Xu G; Peng S; Tang G; Bai L; Zhu M; Zhang Y; Huang Z; Wang P; Liu X; Huang M; Luo Y; Wang X; Yu H
Clin Transl Med; 2023 May; 13(5):e1279. PubMed ID: 37203239
[TBL] [Abstract][Full Text] [Related]
5. S100A4 enhances protumor macrophage polarization by control of PPAR-γ-dependent induction of fatty acid oxidation.
Liu S; Zhang H; Li Y; Zhang Y; Bian Y; Zeng Y; Yao X; Wan J; Chen X; Li J; Wang Z; Qin Z
J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34145030
[TBL] [Abstract][Full Text] [Related]
6. ALKBH5/MAP3K8 axis regulates PD-L1+ macrophage infiltration and promotes hepatocellular carcinoma progression.
You Y; Wen D; Zeng L; Lu J; Xiao X; Chen Y; Song H; Liu Z
Int J Biol Sci; 2022; 18(13):5001-5018. PubMed ID: 35982895
[TBL] [Abstract][Full Text] [Related]
7. Down-regulated FTO and ALKBH5 co-operatively activates FOXO signaling through m6A methylation modification in HK2 mRNA mediated by IGF2BP2 to enhance glycolysis in colorectal cancer.
Ye M; Chen J; Lu F; Zhao M; Wu S; Hu C; Yu P; Kan J; Bai J; Tian Y; Tang Q
Cell Biosci; 2023 Aug; 13(1):148. PubMed ID: 37580808
[TBL] [Abstract][Full Text] [Related]
8. ALKBH5 promotes the development of lung adenocarcinoma by regulating the polarization of M2 macrophages through CDCA4.
Tan J; Chen F; Wang J; Li J; Ouyang B; Li X; Li Y; Zhang W; Jiang Y
Gene; 2024 Feb; 895():147975. PubMed ID: 37949419
[TBL] [Abstract][Full Text] [Related]
9. The m6A demethylase ALKBH5 promotes tumor progression by inhibiting RIG-I expression and interferon alpha production through the IKKε/TBK1/IRF3 pathway in head and neck squamous cell carcinoma.
Jin S; Li M; Chang H; Wang R; Zhang Z; Zhang J; He Y; Ma H
Mol Cancer; 2022 Apr; 21(1):97. PubMed ID: 35395767
[TBL] [Abstract][Full Text] [Related]
10. Distinct RNA
Toh JDW; Crossley SWM; Bruemmer KJ; Ge EJ; He D; Iovan DA; Chang CJ
Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25284-25292. PubMed ID: 32989163
[TBL] [Abstract][Full Text] [Related]
11. Impact of m6A demethylase (ALKBH5, FTO) genetic polymorphism and expression levels on the development of pulmonary tuberculosis.
Zhang TP; Li R; Wang LJ; Li HM
Front Cell Infect Microbiol; 2022; 12():1074380. PubMed ID: 36619747
[TBL] [Abstract][Full Text] [Related]
12. m
Onalan E; Yakar B; Onalan EE; Karakulak K; Kaymaz T; Donder E
J Coll Physicians Surg Pak; 2022 Sep; 32(9):1143-1148. PubMed ID: 36089710
[TBL] [Abstract][Full Text] [Related]
13. Smoking-Induced M2-TAMs, via circEML4 in EVs, Promote the Progression of NSCLC through ALKBH5-Regulated m6A Modification of SOCS2 in NSCLC Cells.
Cheng C; Wang P; Yang Y; Du X; Xia H; Liu J; Lu L; Wu H; Liu Q
Adv Sci (Weinh); 2023 Aug; 10(22):e2300953. PubMed ID: 37246269
[TBL] [Abstract][Full Text] [Related]
14. m
Nagaki Y; Motoyama S; Yamaguchi T; Hoshizaki M; Sato Y; Sato T; Koizumi Y; Wakita A; Kawakita Y; Imai K; Nanjo H; Watanabe H; Imai Y; Minamiya Y; Kuba K
Genes Cells; 2020 Aug; 25(8):547-561. PubMed ID: 32449584
[TBL] [Abstract][Full Text] [Related]
15. Astragalus mongholicus Bunge-Curcuma aromatica Salisb. suppresses growth and metastasis of colorectal cancer cells by inhibiting M2 macrophage polarization via a Sp1/ZFAS1/miR-153-3p/CCR5 regulatory axis.
Gu J; Sun R; Tang D; Liu F; Chang X; Wang Q
Cell Biol Toxicol; 2022 Aug; 38(4):679-697. PubMed ID: 35072892
[TBL] [Abstract][Full Text] [Related]
16. N6-methyladenosine demethylase ALKBH5 suppresses colorectal cancer progression potentially by decreasing PHF20 mRNA methylation.
Zhang Z; Wang L; Zhao L; Wang Q; Yang C; Zhang M; Wang B; Jiang K; Ye Y; Wang S; Shen Z
Clin Transl Med; 2022 Aug; 12(8):e940. PubMed ID: 35979628
[TBL] [Abstract][Full Text] [Related]
17. ALKBH5/YTHDF2-mediated m6A modification of circAFF2 enhances radiosensitivity of colorectal cancer by inhibiting Cullin neddylation.
Shao Y; Liu Z; Song X; Sun R; Zhou Y; Zhang D; Sun H; Huang J; Wu C; Gu W; Zheng X; Jiang J
Clin Transl Med; 2023 Jul; 13(7):e1318. PubMed ID: 37381158
[TBL] [Abstract][Full Text] [Related]
18. RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.
Guo X; Li K; Jiang W; Hu Y; Xiao W; Huang Y; Feng Y; Pan Q; Wan R
Mol Cancer; 2020 May; 19(1):91. PubMed ID: 32429928
[TBL] [Abstract][Full Text] [Related]
19. FAM198B promotes colorectal cancer progression by regulating the polarization of tumor-associated macrophages via the SMAD2 signaling pathway.
Zheng X; Chen J; Nan T; Zheng L; Lan J; Jin X; Cai Y; Liu H; Chen W
Bioengineered; 2022 May; 13(5):12435-12445. PubMed ID: 35587159
[TBL] [Abstract][Full Text] [Related]
20. ALKBH5 inhibits the SIRT3/ACC1 axis to regulate fatty acid metabolism via an m6A-IGF2BP1-dependent manner in cervical squamous cell carcinoma.
Zhen L; Pan W
Clin Exp Pharmacol Physiol; 2023 May; 50(5):380-392. PubMed ID: 36705046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]